Description
CAPSY 500 is an oral chemotherapy tablet containing 500 mg of the active ingredient capecitabine, manufactured to Indian Pharmacopoeia standards. It acts as a prodrug that is converted within the body into the active anti-cancer agent 5-fluorouracil (5-FU), preferentially targeting tumor cells. This medication is primarily prescribed for the treatment of various stage colorectal cancers and advanced or metastatic breast cancer.
Reviews
There are no reviews yet.